Polysaccharide-Based Nanoparticles for Theranostic Nanomedicine
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: closed (10 September 2022) | Viewed by 35647
Special Issue Editor
Special Issue Information
Dear Colleagues,
Due to the enhanced permeability and retention (EPR) effect, nanocarriers can be highly enriched in tumor sites, which is conducive to enhance the circulation time of drugs and enhance the stability of drugs, so they have become a powerful means to enhance the effect of tumor treatment and diagnosis. As a natural biomacromolecule, polysaccharide has good biocompatibility and biological function, and can realize active targeting. For example, hyaluronic acid has the function of specifically targeting CD44 receptor. Natural polysaccharides have become a good carrier for nano delivery systems because of their biocompatibility, biodegradability, low toxicity and unique physical and chemical properties such as hydrophilicity, positive charge and easy modification. Polysaccharide nanoparticles not only have the dual advantages of nanotechnology and polysaccharide, but also have the specificity of highly targeted drug delivery and molecular imaging in the application of theranostic nanomedicine. Polysaccharide based nanoparticles are increasingly used as platforms for simultaneous drug delivery and imaging, so they have become popular therapeutic nanoparticles.
Prof. Dr. Jingdi Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- polysaccharide
- nanoparticles
- therapeutics
- diagnostics
- nano-drugs